Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.
Cui Z, Crane J, Xie H, Jin X, Zhen G, Li C, Xie L, Wang L, Bian Q, Qiu T, Wan M, Xie M, Ding S, Yu B, Cao X.
Cui Z, et al. Among authors: yu b.
Ann Rheum Dis. 2016 Sep;75(9):1714-21. doi: 10.1136/annrheumdis-2015-207923. Epub 2015 Oct 15.
Ann Rheum Dis. 2016.
PMID: 26470720
Free PMC article.